Once again, in the interest of transparency, I want to be upfront about my biases: I am friends with both Cam and Mike and that could certainly be influencing my views about this situation
Reassess total daily insulin dose at 12 weeks on maintenance semaglutide Many patients reduce insulin by 40 to 60% total Some patients discontinue insulin if A1C is at goal (typically below 7%) and glucose is stable Recheck A1C at 3 months to confirm glycemic control Hypoglycemia response: If glucose drops below 54 mg/dL (severe hypoglycemia threshold), treat immediately with 15 grams fast-acting carbohydrate, recheck in 15 minutes, and contact your provider the same day to discuss further insulin reduction
GSNO was used solely as a nitrosylating agent to generate S-nitrosylated TTR, as previously shown [64], and excess reagent was removed prior to analysis
Vital, Canadas pharmaceutical supply chain alliance, confirmed that generic semaglutide products are on their way to pharmacies but are going through distributors first
Clinically, kisspeptin is being studied to induce ovulation in individuals who are poor responders to other stimulants and could potentially decrease the likelihood of ovarian hyperstimulation